Mathurin Flamant

937 total citations
8 papers, 587 citations indexed

About

Mathurin Flamant is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Mathurin Flamant has authored 8 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Mathurin Flamant's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (4 papers) and Systemic Lupus Erythematosus Research (2 papers). Mathurin Flamant is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (4 papers) and Systemic Lupus Erythematosus Research (2 papers). Mathurin Flamant collaborates with scholars based in France and Belgium. Mathurin Flamant's co-authors include Xavier Roblin, David Laharie, Jean–Yves Mary, Yoram Bouhnik, Hélène Pillant, Éric Piver, Gwénola Vernier-Massouille, Marc Lémann, Raymond Jian and Guillaume Savoye and has published in prestigious journals such as Gastroenterology, Clinical Gastroenterology and Hepatology and Inflammatory Bowel Diseases.

In The Last Decade

Mathurin Flamant

8 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathurin Flamant France	7	532	417	174	145	57	8	587
Sophie Tops Belgium	14	531 1.0×	406 1.0×	131 0.8×	308 2.1×	48 0.8×	16	643
Sue P. Irwin Canada	7	495 0.9×	377 0.9×	135 0.8×	221 1.5×	43 0.8×	8	613
Hélène Pillant France	5	473 0.9×	380 0.9×	198 1.1×	117 0.8×	52 0.9×	7	539
Melanie Rinaudo France	5	417 0.8×	327 0.8×	83 0.5×	197 1.4×	63 1.1×	7	472
Siddharth Bhatia India	9	376 0.7×	227 0.5×	116 0.7×	108 0.7×	39 0.7×	17	472
Jean-François Simon France	5	509 1.0×	412 1.0×	268 1.5×	63 0.4×	44 0.8×	13	663
Mélanie Rinaudo-Gaujous France	8	327 0.6×	231 0.6×	73 0.4×	175 1.2×	89 1.6×	15	487
Philippe Godeberge France	13	346 0.7×	297 0.7×	315 1.8×	71 0.5×	89 1.6×	25	687
Nicolas de Suray Belgium	4	402 0.8×	362 0.9×	101 0.6×	138 1.0×	42 0.7×	6	522
Manuel Van Domselaar Spain	10	374 0.7×	292 0.7×	177 1.0×	112 0.8×	133 2.3×	25	541

Countries citing papers authored by Mathurin Flamant

Since Specialization

Citations

This map shows the geographic impact of Mathurin Flamant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathurin Flamant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathurin Flamant more than expected).

Fields of papers citing papers by Mathurin Flamant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathurin Flamant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathurin Flamant. The network helps show where Mathurin Flamant may publish in the future.

Co-authorship network of co-authors of Mathurin Flamant

This figure shows the co-authorship network connecting the top 25 collaborators of Mathurin Flamant. A scholar is included among the top collaborators of Mathurin Flamant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathurin Flamant. Mathurin Flamant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Bouhnik, Yoram, Franck Carbonnel, Mathurin Fuméry, et al.. (2023). The PERFUSE study: The experience of patients receiving Adalimumab biosimilar SB5. Digestive and Liver Disease. 55(12). 1658–1666. 4 indexed citations

Nachury, Maria, Arnaud Bourreille, Laurent Peyrin‐Biroulet, et al.. (2022). Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study. BMC Gastroenterology. 22(1). 498–498. 10 indexed citations

Bouguen, Guillaume, Audrey Payancé, Aurélien Amiot, et al.. (2019). Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease. Clinical Gastroenterology and Hepatology. 18(3). 628–636. 15 indexed citations

Roblin, Xavier, Pauline Rivière, Mathurin Flamant, et al.. (2018). Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24(9). 1904–1909. 9 indexed citations

Flamant, Mathurin & Xavier Roblin. (2018). Inflammatory bowel disease: towards a personalized medicine. Therapeutic Advances in Gastroenterology. 11. 1756283X17745029–1756283X17745029. 59 indexed citations

Flamant, Mathurin, Stéphane Paul, & Xavier Roblin. (2017). Golimumab for the treatment of ulcerative colitis. Expert Opinion on Biological Therapy. 17(7). 879–886. 24 indexed citations

Louis, Édouard, Jean–Yves Mary, Gwénola Vernier-Massouille, et al.. (2011). Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped. Gastroenterology. 142(1). 63–70.e5. 429 indexed citations

Louis, Édouard, Gwénola Vernier-Massouille, Jean–Charles Grimaud, et al.. (2009). 961 Infliximab Discontinuation in Crohn's Disease Patients in Stable Remission On Combined Therapy with Immunosuppressors: A Prospective Ongoing Cohort Study. Gastroenterology. 136(5). A–146. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact